Ticker Details
Vera Therapeutics, Inc.
IPO Date:	May 14, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$3.05B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.90 | 3.73%
Avg Daily Range (30 D):	$1.00 | 2.77%
Avg Daily Range (90 D):	$0.96 | 2.52%

Institutional Daily Volume
Avg Daily Volume:	.62M
Avg Daily Volume (30 D):	1.68M
Avg Daily Volume (90 D):	1.22M

Trade Size
Avg Trade Size (Sh.):	70
Avg Trade Size (Sh.) (30 D):	70
Avg Trade Size (Sh.) (90 D):	64

Institutional Trades
Total Institutional Trades:	2,371
Avg Institutional Trade:	$2.45M
Avg Institutional Trade (30 D):	$3.52M
Avg Institutional Trade (90 D):	$3.4M
Avg Institutional Trade Volume:	.08M
Avg Institutional Trades (Per Day):	3

Market Closing Trades
Avg Closing Trade:	$4.06M
Avg Closing Trade (30 D):	$7.82M
Avg Closing Trade (90 D):	$7.1M
Avg Closing Volume:	126.88K

News

Jul 9, 2026 @ 12:00 PM Vera Therapeutics Announces Appointment of Nancy B... Source: Na

May 26, 2026 @ 6:29 PM Investment Firm Closes Out Entire $18.1 Million Po... Source: Jake Lerch

Apr 29, 2026 @ 5:00 PM IgA Nephropathy Market Forecast to 2036: Novel The... Source: Delveinsight

Apr 6, 2026 @ 5:00 PM Idiopathic Membranous Nephropathy Market is Predic... Source: Delveinsight

Mar 13, 2026 @ 2:36 PM This Fund Bet $200 Million on a Biotech Stock Up 5... Source: Jonathan Ponciano

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-5.54	$-1.69	$-1.39
Diluted EPS	$-5.54	$-1.69	$-1.39
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-368.95M	$-121.03M	$-91.1M
Operating Income / Loss	$-383.41M	$-125.13M	$-94.21M
Cost of Revenue
Net Cash Flow	$59.26M	$-240.37M	$296.95M
PE Ratio